The study of the new drug isatuximab, also known as Sarclisa, showed significant promise in treating multiple myeloma patients whose cancer has returned, dramatically increasing overall survival A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback